Clinical Trial Update: Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia [Phase 3]

View source ↗

Summary

Phase 3 trial of KHK7580 in subjects with secondary hyperparathyroidism in Asia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• KHK7580

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Secondary Hyperparathyroidism | Phase 3 | Status: COMPLETED